- Goals of the Symposium
- Target Audience
- Symposium Location
- Executive Committee
- Program Planning Committee
Goals of the Symposium
The San Antonio Breast Cancer Symposium® is designed to provide state-of-the-art information on the experimental biology, etiology, prevention, diagnosis, and therapy of breast cancer and premalignant breast disease to an international audience of academic and private physicians and researchers.
The scientific program consists of formal lectures by experts in clinical, translational, and basic research; selected slide and poster presentations; forums; and case discussions. The official language of the symposium is English. Simultaneous translation is not provided.
Target Audience
This international Symposium is directed primarily toward academic and private physicians and researchers involved in breast cancer in medical, surgical, gynecologic, and radiation oncology, as well as patient advocates and other appropriate health care professionals. SABCS expects over 10,000 attendees from more than 102 countries will attend in 2025.
Symposium Location
The Symposium is held at the Henry B. Gonzalez Convention Center, 900 E. Market Street, San Antonio, Texas. Attendees also have the opportunity to access the virtual meeting.
Executive Committee
- Carlos L. Arteaga, MD
UT Southwestern, Harold C. Simmons Cancer Center, Dallas, Texas, Symposium Co-director - Virginia G. Kaklamani, MD
UT Health San Antonio Mays Cancer Center, San Antonio, Texas, Symposium Co-director - Kate Lathrop, MD
UT Health San Antonio Mays Cancer Center, San Antonio, Texas, Symposium Program Director - Carissia Calvo-Strube, MD
University of Texas Health Science Center San Antonio, San Antonio, Texas - Margaret Foti, PhD, MD (hc)
American Association for Cancer Research, Philadelphia, Pennsylvania - Charles M. Perou, PhD
University of North Carolina, Chapel Hill, North Carolina - Hope Rugo, MD
University of California San Francisco Helen Diller Family Comprehensive Cancer Center, San Francisco, California - Christina Curtis, PhD, MSc
Stanford University, Palo Alto, California - Lei Zheng, MD, PhD
University of Texas Health San Antonio Mays Cancer Center, San Antonio, Texas
Program Planning Committee
- Laleh Amiri Kordestani
U.S. Food and Drug Administration (FDA), Silver Spring, Maryland - Carole Baas, PhD
Advocate, Physical Sciences in Oncology Network at the (USA) National Cancer Institute, Southlake, Texas - Sunil Badve, MD
Emory Winship Cancer Institute, Atlanta, Georgia - Justin Balko, PharmD, PhD
Vanderbilt University Medical Center, Nashville, Tennessee - Phillippe Bedard, MD
Princess Margaret Cancer Centre, Toronto, Ontario - Vernal Branch
Independent Research Patient Advocate, Richmond, Virginia - Sarat Chandarlapaty, MD, PhD
Memorial Sloan Kettering Cancer Center, New York, New York - Mariana Chavez Mac Gregor, MD, MSC
MD Anderson Cancer Center, Houston, Texas - Fergus Couch, PhD
Mayo Clinic, Rochester, Minnesota - Javier Cortés, MD, PhD
International Breast Cancer Center, Barcelona, Spain - Christine Desmedt, PhD
Katholieke Universiteit Leuven, Leuven, Belgium - Leif Ellisen, MD, PhD
Harvard University, Cambridge, Massachusetts - Sally Friedewald, MD
Massachusetts General Hospital, Boston, Massachusetts - William Gradishar, MD
Northwestern University Feinberg School of Medicine, Chicago, Illinois - Erika Hamilton, MD
Sarah Cannon Research Institute, Nashville, Tennessee - Christine Hodgdon
Advocate, Guiding Researchers & Advocates to Scientific Partnerships (GRASP). Baltimore, Maryland - Kelly Hunt, MD, PhD
MD Anderson Cancer Center, Houston, Texas - Komal Jhaveri, MD, FACP
Memorial Sloan Kettering Cancer Center, New York, New York - Mary Jimenez
Advocate, Alamo Breast Cancer Foundation, San Antonio, Texas - Seema Khan, MD
Northwestern University Feinberg School of Medicine, Chicago, Illinois - Aleix Prat, MD
Clinic Barcelona, Barcelona, Spain - Sonya Reid, MD, MPH
Vanderbilt-Ingram Cancer Center, Nashville, Tennessee - Tara Sanft, MD
Yale School of Medicine, New Haven, Connecticut - Zhi-Ming Shao, MD, PhD
Fudan University Cancer Institute, Shanghai, China - Jonathan Strauss, MD
Northwestern University Feinberg School of Medicine, Chicago, Illinois - Alexandra Thomas, MD, FACP
Duke Cancer Institute, Durham, North Carolina - Evanthia Roussos Thomas, MD, PhD
University of Southern California, Los Angeles, California - Qing Zhang, PhD
UT Southwestern Medical Center, Dallas, Texas